Skip to main content
TipRanks
Go Ultimate75% OFF

Eledon Pharmaceuticals (ELDN) Stock Forecast & Price Target

1,054 Followers
See the Price Targets and Ratings of:

ELDN Analyst Ratings

Strong Buy
3Ratings
3Buy0Hold0Sell
Based on 3 analysts giving stock ratings to Eledon Pharmaceuticals in the past 3 months

ELDN Stock 12 Month Forecast

$8.67▲(224.59% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Eledon Pharmaceuticals in the last 3 months. The average price target is $8.67 with a high forecast of $10.00 and a low forecast of $8.00. The average price target represents a 224.59% change from the last price of $2.67.
Highest Price Target$10.00Average Price Target$8.67Lowest Price Target$8.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for ELDN
Price TargetArticle
Noble Financial$10buy274.53%UpsideReiterated09/23/26
LifeSci Capital$8buy199.63%UpsideReiterated09/22/26
Guggenheim Analyst forecast on ELDNUnknown AnalystNot RankedGuggenheim$8buy199.63%UpsideReiterated08/13/26
Rodman & Renshaw$12buy349.44%UpsideInitiated07/21/26
Craig-Hallum―buy―Reiterated01/23/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings
MDWDMediwound
IMUXImmunic
OVIDOvid Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Eledon Pharmaceuticals

3 Months
Robert LeBoyer
Robert LeBoyerNoble Financial
Success Rate9/20 ratings generated profit
45%
Average Return
+6.05%

Copying Robert LeBoyer's trades and holding each position for 3 Months would result in 45.00% of your transactions generating a profit, with an average return of +6.05% per trade.

1 Year
Robert LeBoyer
Robert LeBoyerNoble Financial
Success Rate12/20 ratings generated profit
60%
Average Return
+22.52%

Copying Robert LeBoyer's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +22.52% per trade.

2 Years
Robert LeBoyer
Robert LeBoyerNoble Financial
Success Rate9/20 ratings generated profit
45%
Average Return
+14.04%

Copying Robert LeBoyer's trades and holding each position for 2 Years would result in 45.00% of your transactions generating a profit, with an average return of +14.04% per trade.

ELDN Analyst Recommendation Trends

05101520Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for ELDN
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy1010874
Buy00000
Hold00000
Sell00000
Strong Sell00000
total1010874

In the current month, ELDN has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ELDN average Analyst price target in the past 3 months is 8.67.

ELDN Financial Forecast

$-2$-1.5$-1$-0.5$0Q4 2025Q2 2026Q3 2026
High$-0.15
Consensus$-0.19
Low$-0.21

ELDN Earnings Forecast

Next quarter’s earnings estimate for ELDN is -$0.19 with a range of -$0.21 to -$0.15. The previous quarter’s EPS was -$0.27. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$-1$-0.5$0$0.5$1Q4 2025Q2 2026Q3 2026
High$0.00
Consensus$0.00
Low$0.00

ELDN Sales Forecast

Next quarter’s sales forecast for ELDN is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

ELDN Stock Forecast FAQ

What is ELDN’s average 12-month price target, according to analysts?
Based on analyst ratings, Eledon Pharmaceuticals’s 12-month average price target is $8.67.
What is ELDN’s upside potential, based on the analysts’ average price target?
Eledon Pharmaceuticals has 224.59% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ELDN a Buy, Sell or Hold?
Eledon Pharmaceuticals has a consensus rating of Strong Buy which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Eledon Pharmaceuticals’s price target?
The average price target for Eledon Pharmaceuticals is $8.67. This is based on 3 12-month price targets, issued in the past 3 months. The highest analyst price target is $10.00, the lowest forecast is $8.00. The average price target represents a 224.59% increase from the current price of $2.67.
What do analysts say about Eledon Pharmaceuticals?
Eledon Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of ELDN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.